Science Magazine Podcast
New treatments for deadly snake bites, and a fusion company that wants to get in the medical isotopes game
Jul 18, 2024
Ph.D. candidate Tian Du discusses finding antivenom treatments by screening human genes for deadly snake bites, specifically targeting spitting cobra venom. A fusion company plans to use high-energy neutrons from fusion reactors for medical isotopes before transitioning to energy sales. The podcast explores innovative approaches to medical isotopes, challenges in current antivenom production, and potential treatments using CRISPR and heparin to counter snake venom toxicity.
31:33
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Fusion company focuses on using high-energy neutrons from reactors for medical isotopes and X-ray imaging.
- Research explores CRISPR screening to identify human genes for potential antivenom development against snake venoms.
Deep dives
NOLSTER's Biomedical Research Focus
NOLSTER specializes in researching postbiotic gut microbiota metabolite-based pharmaceuticals for treating metabolic and immune-related diseases. Products include GMP bacteria preparations and QMEC, a unique postbiotics healthcare supplement. Analytical services offered cover liquid chromatography, mass spectroscopy metabolic analysis, and advanced genetic sequencing for gut microbiota. NOLSTER's dedication to innovative research aims to address ongoing health challenges.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
